Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

4.44
Delayed Data
As of May 27
 +0.17 / +3.98%
Today’s Change
3.12
Today|||52-Week Range
52.90
-55.73%
Year-to-Date

Today’s Trading

Previous close4.27
Today’s open4.31
Day’s range4.21 - 4.49
Volume249,993
Average volume (3 months)901,827
Market cap$162.5M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+5.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+190.80%
Revenue growth (last year)+28.45%
P/E ratioNM
Price/Sales30.26
Price/Book0.80

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc+0.07+1.86%
DRRXDURECT Corp-0.01-0.83%
GLYCGlycoMimetics Inc+0.23+2.79%
LPCNLipocine Inc+0.03+0.33%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$11.7M
Annual profit (last year)-$83.2M
Net profit margin-711.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Guy MacDonald
Chief Financial &
Accounting Officer
Christopher Watt
Corporate headquarters
Watertown, Massachusetts

Forecasts

Partner Offers

Search for Jobs